Loss of p16INK4a expression correlates with decreased survival in Pediatric osteosarcomas

Anirban Maitra, Helen Roberts, Arthur G. Weinberg, Joseph Geradts

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Abnormalities of the G1 cell-cycle checkpoint are commonly reported in cancers at various anatomic sites. pRB, p16INK4a and cyclin D1 are critical G1-checkpoint proteins responsible for maintaining the balance of cellular proliferation. We examined a series of 38 pediatric osteosarcomas for abnormal expression of pRB, p16INK4a and cyclin D1 by immunohistochemical analysis of archival biopsy specimens. Overall, 17/38 (45%) osteosarcomas showed evidence of G1-checkpoint abrogation, including 11/38 (29%) with loss of pRB expression and 6/38 (16%) with loss of p16INK4a expression. Cyclin D1 over-expression was not detected. There was an inverse correlation between loss of pRB and p16INK4a expression (p = 0.07). pRB and p16INK4a abnormalities were independent of site of disease, presence of metastasis at diagnosis and percentage of tumor necrosis in the resection specimen. Clinical follow-up was available on all patients (median 31.6 months, range 5.9-116 months). Absence of p16INK4a expression significantly correlated with decreased survival in univariate analysis (p = 0.03), while loss of pRB expression did not affect survival. Immunohistochemical analysis of p16INK4a expression in pediatric osteosarcomas may be a useful adjunctive marker of prognosis.

Original languageEnglish (US)
Pages (from-to)34-38
Number of pages5
JournalInternational Journal of Cancer
Volume95
Issue number1
DOIs
StatePublished - Jan 20 2001

Fingerprint

Cyclin D1
Osteosarcoma
Pediatrics
Survival
G1 Phase Cell Cycle Checkpoints
Neoplasms
Necrosis
Cell Proliferation
Neoplasm Metastasis
Biopsy
Proteins

Keywords

  • Cyclin D1
  • Immunohistochemistry
  • Osteosarcoma
  • P16
  • Pediatric
  • PRB
  • Survival

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Loss of p16INK4a expression correlates with decreased survival in Pediatric osteosarcomas. / Maitra, Anirban; Roberts, Helen; Weinberg, Arthur G.; Geradts, Joseph.

In: International Journal of Cancer, Vol. 95, No. 1, 20.01.2001, p. 34-38.

Research output: Contribution to journalArticle

Maitra, Anirban ; Roberts, Helen ; Weinberg, Arthur G. ; Geradts, Joseph. / Loss of p16INK4a expression correlates with decreased survival in Pediatric osteosarcomas. In: International Journal of Cancer. 2001 ; Vol. 95, No. 1. pp. 34-38.
@article{5f4034b531a6474b88a88a21bdfd76d4,
title = "Loss of p16INK4a expression correlates with decreased survival in Pediatric osteosarcomas",
abstract = "Abnormalities of the G1 cell-cycle checkpoint are commonly reported in cancers at various anatomic sites. pRB, p16INK4a and cyclin D1 are critical G1-checkpoint proteins responsible for maintaining the balance of cellular proliferation. We examined a series of 38 pediatric osteosarcomas for abnormal expression of pRB, p16INK4a and cyclin D1 by immunohistochemical analysis of archival biopsy specimens. Overall, 17/38 (45{\%}) osteosarcomas showed evidence of G1-checkpoint abrogation, including 11/38 (29{\%}) with loss of pRB expression and 6/38 (16{\%}) with loss of p16INK4a expression. Cyclin D1 over-expression was not detected. There was an inverse correlation between loss of pRB and p16INK4a expression (p = 0.07). pRB and p16INK4a abnormalities were independent of site of disease, presence of metastasis at diagnosis and percentage of tumor necrosis in the resection specimen. Clinical follow-up was available on all patients (median 31.6 months, range 5.9-116 months). Absence of p16INK4a expression significantly correlated with decreased survival in univariate analysis (p = 0.03), while loss of pRB expression did not affect survival. Immunohistochemical analysis of p16INK4a expression in pediatric osteosarcomas may be a useful adjunctive marker of prognosis.",
keywords = "Cyclin D1, Immunohistochemistry, Osteosarcoma, P16, Pediatric, PRB, Survival",
author = "Anirban Maitra and Helen Roberts and Weinberg, {Arthur G.} and Joseph Geradts",
year = "2001",
month = "1",
day = "20",
doi = "10.1002/1097-0215(20010120)95:1<34::AID-IJC1006>3.0.CO;2-V",
language = "English (US)",
volume = "95",
pages = "34--38",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Loss of p16INK4a expression correlates with decreased survival in Pediatric osteosarcomas

AU - Maitra, Anirban

AU - Roberts, Helen

AU - Weinberg, Arthur G.

AU - Geradts, Joseph

PY - 2001/1/20

Y1 - 2001/1/20

N2 - Abnormalities of the G1 cell-cycle checkpoint are commonly reported in cancers at various anatomic sites. pRB, p16INK4a and cyclin D1 are critical G1-checkpoint proteins responsible for maintaining the balance of cellular proliferation. We examined a series of 38 pediatric osteosarcomas for abnormal expression of pRB, p16INK4a and cyclin D1 by immunohistochemical analysis of archival biopsy specimens. Overall, 17/38 (45%) osteosarcomas showed evidence of G1-checkpoint abrogation, including 11/38 (29%) with loss of pRB expression and 6/38 (16%) with loss of p16INK4a expression. Cyclin D1 over-expression was not detected. There was an inverse correlation between loss of pRB and p16INK4a expression (p = 0.07). pRB and p16INK4a abnormalities were independent of site of disease, presence of metastasis at diagnosis and percentage of tumor necrosis in the resection specimen. Clinical follow-up was available on all patients (median 31.6 months, range 5.9-116 months). Absence of p16INK4a expression significantly correlated with decreased survival in univariate analysis (p = 0.03), while loss of pRB expression did not affect survival. Immunohistochemical analysis of p16INK4a expression in pediatric osteosarcomas may be a useful adjunctive marker of prognosis.

AB - Abnormalities of the G1 cell-cycle checkpoint are commonly reported in cancers at various anatomic sites. pRB, p16INK4a and cyclin D1 are critical G1-checkpoint proteins responsible for maintaining the balance of cellular proliferation. We examined a series of 38 pediatric osteosarcomas for abnormal expression of pRB, p16INK4a and cyclin D1 by immunohistochemical analysis of archival biopsy specimens. Overall, 17/38 (45%) osteosarcomas showed evidence of G1-checkpoint abrogation, including 11/38 (29%) with loss of pRB expression and 6/38 (16%) with loss of p16INK4a expression. Cyclin D1 over-expression was not detected. There was an inverse correlation between loss of pRB and p16INK4a expression (p = 0.07). pRB and p16INK4a abnormalities were independent of site of disease, presence of metastasis at diagnosis and percentage of tumor necrosis in the resection specimen. Clinical follow-up was available on all patients (median 31.6 months, range 5.9-116 months). Absence of p16INK4a expression significantly correlated with decreased survival in univariate analysis (p = 0.03), while loss of pRB expression did not affect survival. Immunohistochemical analysis of p16INK4a expression in pediatric osteosarcomas may be a useful adjunctive marker of prognosis.

KW - Cyclin D1

KW - Immunohistochemistry

KW - Osteosarcoma

KW - P16

KW - Pediatric

KW - PRB

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=0035915773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035915773&partnerID=8YFLogxK

U2 - 10.1002/1097-0215(20010120)95:1<34::AID-IJC1006>3.0.CO;2-V

DO - 10.1002/1097-0215(20010120)95:1<34::AID-IJC1006>3.0.CO;2-V

M3 - Article

C2 - 11241308

AN - SCOPUS:0035915773

VL - 95

SP - 34

EP - 38

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 1

ER -